B. A. Bengtsson and B. E. Malmvall, The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications, Arthritis Rheum, vol.24, pp.899-904, 1981.

I. Vodopivec and J. F. Rizzo, Ophthalmic manifestations of giant cell arteritis, Rheumatology (Oxford), vol.57, pp.63-72, 2018.

M. A. Gonzalez-gay, J. A. Miranda-filloy, and M. J. Lopez-diaz, Giant cell arteritis i northwestern Spain : a 25-year epidemiologic study, Medicine (Baltimore), vol.86, pp.61-69, 2007.

M. A. Gonzalez-gay, S. Castaneda, and J. Llorca, Giant Cell Arteritis: Visual loss is our major concern, J Rheumatol, vol.43, pp.1458-61, 2016.

J. J. Chen, J. A. Leavitt, C. Fang, C. S. Crowson, E. L. Matteson et al., Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis, Ophthalmology, vol.123, pp.1999-2003, 2016.

S. S. Hayreh, P. A. Podhajsky, and B. Zimmerman, Ocular manifestations of giant cell arteritis

, Am J Ophthalmol, vol.125, pp.509-520, 1998.

H. Danesh-meyer, P. J. Savino, and G. G. Gamble, Poor prognosis of visual outcome after visual loss from giant cell arteritis, Ophthalmology, vol.112, pp.1098-1103, 2005.

E. Liozon, F. Herrmann, and K. Ly, Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients, Am J Med, vol.111, pp.211-217, 2001.

C. Salvarani, L. Cimino, and P. Macchioni, Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis, Arthritis Rheum, vol.53, pp.293-297, 2005.

M. C. Cid, C. Font, and J. Oristrell, Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis, Arthritis Rheum, vol.41, pp.26-32, 1998.

A. G. Singh, T. A. Kermani, C. S. Crowson, C. M. Weyand, E. L. Matteson et al., Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort, J Rheumatol, vol.42, pp.309-315, 2015.

M. A. Gonzalez-gay, C. Garcia-porrua, and J. Llorca, Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients, Medicine (Baltimore), vol.79, pp.283-292, 2000.

G. G. Hunder, D. A. Bloch, and B. A. Michel, The American college of rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, vol.33, pp.1122-1128, 1990.

H. De-boysson, E. Liozon, and K. H. Ly, Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control study, Clin Rheumatol, vol.37, pp.3405-3410, 2018.

H. De-boysson, A. Daumas, and M. Vautier, Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients, Autoimmun Rev, vol.17, pp.391-398, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02263732

A. Dumont, J. J. Parienti, and C. Delmas, Factors associated with relapse and dependence to glucocorticoids in giant-cell arteritis, J Rheumatol, p.181127, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02153822

H. De-boysson, E. Liozon, and D. Lariviere, Giant cell arteritis-related stroke: a retrospective multicenter case-control study, J Rheumatol, vol.44, pp.297-303, 2017.

M. A. Gonzalez-gay, T. R. Vazquez-rodriguez, and I. Gomez-acebo, Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis, Medicine (Baltimore), vol.88, pp.227-235, 2009.

M. Yates, A. J. Macgregor, and J. Robson, The association of vascular risk factors with visual loss in giant cell arteritis, Rheumatology (Oxford), vol.56, pp.524-528, 2017.

G. T. Liu, J. S. Glaser, N. J. Schatz, and J. L. Smith, Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision, Ophthalmology, vol.101, pp.1779-1785, 1994.

M. A. Gonzalez-gay, C. Garcia-porrua, J. Llorca, C. Gonzalez-louzao, and P. Rodriguez-ledo, Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy, Semin Arthritis Rheum, vol.30, pp.249-56, 2001.

M. J. Lopez-diaz, J. Llorca, C. Gonzalez-juanatey, J. L. Pena-sagredo, J. Martin et al., The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis, Semin Arthritis Rheum, vol.38, pp.116-139, 2008.

B. Bienvenu, K. H. Ly, and M. Lambert, Management of giant cell arteritis: recommendations of the French study group for large vessel vasculitis (GEFA), Rev Med Interne, vol.37, pp.154-165, 2016.

B. Dasgupta, F. A. Borg, and N. Hassan, BSR and BHPR guidelines for the management of giant cell arteritis, Rheumatology (Oxford), vol.49, pp.1594-1597, 2010.

S. S. Hayreh, B. Zimmerman, and R. H. Kardon, Visual improvement with corticosteroid therapy in giant cell arteritis, Acta Ophthalmol Scand, vol.80, pp.355-367, 2002.

S. S. Hayreh and B. Zimmerman, Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy, Ophthalmology, vol.110, pp.1204-1215, 2003.

A. Hocevar, Z. Rotar, and R. Jese, Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study, Medicine (Baltimore), vol.95, p.3210, 2016.

F. Laskou, F. Coath, S. L. Mackie, S. Banerjee, T. Aung et al., A probability score to aid the diagnosis of suspected giant cell arteritis, Clin Exp Rheumatol, 2019.

A. P. Diamantopoulos, G. Haugeberg, A. Lindland, and G. Myklebust, The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?, Rheumatology (Oxford), vol.55, pp.66-70, 2016.

P. Patil, M. Williams, and W. W. Maw, Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study, Clin Exp Rheumatol, vol.33, pp.103-106, 2015.